Bausch + Lomb (NYSE:BLCO) Price Target Raised to $19.00

Key Points

• Wells Fargo raised Bausch + Lomb’s price target to $19 from $18 while maintaining an “equal weight” rating; the new target implies roughly 8.1% downside from the stock’s $20.67 price.
• Analyst sentiment remains mixed, with an overall “Hold” consensus and an average price target of $19.54, despite ratings ranging from Strong Buy to Sell.
• Bausch + Lomb reported quarterly EPS of $0.34, exceeding the $0.21 consensus, while revenue rose 7.3% year over year to about $1.38 billion and also topped expectations.

Bausch + Lomb (NYSE:BLCO - Get Free Report) had its target price lifted by equities research analysts at Wells Fargo & Company from $18.00 to $19.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Wells Fargo & Company's price target suggests a potential downside of 8.10% from the stock's current price.

A number of other equities analysts have also recently commented on BLCO. Needham & Company LLC restated a "hold" rating on shares of Bausch + Lomb in a report on Tuesday, September 15th. UBS Group started coverage on shares of Bausch + Lomb in a research note on Thursday, July 30th. They set a "buy" rating and a $21.00 price target on the stock. Leerink Partners initiated coverage on shares of Bausch + Lomb in a research report on Wednesday, September 9th. They set an "outperform" rating and a $24.00 price target on the stock. Weiss Ratings raised shares of Bausch + Lomb from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 21st. Finally, Evercore set a $17.00 price objective on shares of Bausch + Lomb in a report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Bausch + Lomb currently has an average rating of "Hold" and an average price target of $19.54.

Bausch + Lomb Trading Up 1.3%

NYSE:BLCO traded up $0.27 during trading hours on Thursday, reaching $20.67. 429,154 shares of the stock were exchanged, compared to its average volume of 450,512. Bausch + Lomb has a twelve month low of $14.44 and a twelve month high of $21.36. The business has a 50-day moving average of $17.24 and a two-hundred day moving average of $16.66. The company has a market capitalization of $7.39 billion, a price-to-earnings ratio of -43.54, a PEG ratio of 0.55 and a beta of 0.56. The company has a quick ratio of 1.02, a current ratio of 1.55 and a debt-to-equity ratio of 0.79.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.13. The business had revenue of $1.38 billion during the quarter, compared to analysts' expectations of $1.37 billion. Bausch + Lomb had a positive return on equity of 4.14% and a negative net margin of 3.21%. The company's revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.18 earnings per share. On average, equities analysts predict that Bausch + Lomb will post 0.81 EPS for the current year.

Insider Transactions at Bausch + Lomb

In related news, Director Eschenbach Andrew C. Von sold 12,500 shares of the firm's stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $16.50, for a total value of $206,250.00. Following the sale, the director owned 69,792 shares of the company's stock, valued at $1,151,568. This trade represents a 15.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Frederick Munsch sold 52,900 shares of Bausch + Lomb stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $16.78, for a total transaction of $887,662.00. Following the completion of the transaction, the chief accounting officer owned 45,831 shares of the company's stock, valued at $769,044.18. This represents a 53.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 71,459 shares of company stock valued at $1,194,370. Corporate insiders own 1.45% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Whitebox Advisors LLC raised its holdings in shares of Bausch + Lomb by 15.8% in the 1st quarter. Whitebox Advisors LLC now owns 1,101,854 shares of the company's stock valued at $17,519,000 after purchasing an additional 150,641 shares in the last quarter. Beach Point Capital Management LP acquired a new position in shares of Bausch + Lomb during the third quarter worth $5,882,000. Sei Investments Co. grew its stake in shares of Bausch + Lomb by 100.0% during the first quarter. Sei Investments Co. now owns 139,266 shares of the company's stock worth $2,214,000 after purchasing an additional 69,633 shares in the last quarter. Engineers Gate Manager LP acquired a new position in shares of Bausch + Lomb during the second quarter worth $1,479,000. Finally, Dimensional Fund Advisors LP increased its holdings in Bausch + Lomb by 13.2% in the first quarter. Dimensional Fund Advisors LP now owns 85,779 shares of the company's stock valued at $1,362,000 after buying an additional 9,971 shares during the last quarter. Institutional investors and hedge funds own 11.07% of the company's stock.

Bausch + Lomb News Roundup

Here are the key news stories impacting Bausch + Lomb this week:

• Positive Sentiment: Raised 2026 guidance: Bausch + Lomb increased its revenue outlook to $5.450 billion-$5.550 billion and adjusted EBITDA guidance to $1.090 billion-$1.140 billion, citing continued momentum from Vision ’27. Bausch + Lomb raises 2026 guidance
• Positive Sentiment: Beat earnings expectations: Third-quarter adjusted EPS was $0.34, well above the $0.21 consensus estimate and up from $0.18 in the year-earlier quarter. The earnings upside was a key driver of the bullish reaction. Bausch + Lomb surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Revenue exceeded forecasts: Quarterly revenue reached approximately $1.375 billion-$1.38 billion, ahead of the $1.37 billion consensus and approximately 7.3% higher year over year. Strong eye-care growth supported the performance. Bausch + Lomb third-quarter earnings results
• Positive Sentiment: Improved profitability: The company swung to a third-quarter profit on an adjusted basis, with earnings substantially ahead of expectations. Management’s earnings call emphasized ongoing operating momentum and the Vision ’27 plan. Bausch + Lomb Q3 2026 earnings call transcript
• Neutral Sentiment: Despite the strong adjusted results, Bausch + Lomb continues to report a negative net margin, so investors will monitor whether revenue growth and the Vision ’27 initiatives translate into sustained GAAP profitability.

About Bausch + Lomb

Bausch + Lomb Corporation NYSE: BLCO is a global eye-health company that develops, manufactures and markets products for vision care, ophthalmic pharmaceuticals and eye surgery. The company serves consumers, eye-care professionals, hospitals and surgical centers through a portfolio spanning contact lenses, contact-lens care products, prescription medicines, over-the-counter eye-care products and surgical equipment.

Its vision-care portfolio includes the Biotrue and INFUSE contact-lens brands, as well as solutions and other products used to clean and maintain contact lenses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.